-

Genentech and C3 AI Improve the Complex Biologics Manufacturing Process with AI

AI insights from C3 AI Reliability increase equipment uptime, lower maintenance costs

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3 AI (NYSE: AI), the Enterprise AI application software company, today announced that Genentech, the medical biotechnology company, has selected C3 AI Reliability as the continued provider for AI-based predictive maintenance software on the company’s biologics manufacturing equipment.

The biotechnology company began using the AI application in 2021 to ensure centrifuges in the facility remained operational, with patients ultimately benefiting by receiving their medicines on time. Genentech uses this facility to manufacture biologics, a specific class of medicine that is extremely complex, time consuming, and resource intensive to develop and deliver to patients. These medicines help patients with some of the most difficult to treat diseases, from multiple sclerosis and macular degeneration to blood cancers such as lymphoma and leukemia.

“We’re proud to partner with Genentech, a company well-known for delivering breakthrough medical innovations for patients, and support its efforts with a robust AI program that allows what is an involved manufacturing process to operate efficiently and ensure patients get the care they need on time,” said C3 AI CEO Thomas M. Siebel.

In 2022, Genentech expanded its use of C3 AI Reliability to new assets beyond centrifuges — scaling its AI footprint to around 200 pieces of equipment total. In addition to increasing the number of assets, the company also broadened employee training for the C3 AI Platform, on which the predictive maintenance application runs. The biotechnology company now has nearly 200 users — from data scientists to facility managers — who are trained on the C3 AI Platform and regularly use the AI application to evaluate equipment health and maintain manufacturing operations.

About C3.ai, Inc.

C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications, C3 AI applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally, and C3 Generative AI, a suite of large AI transformer models for the enterprise.

Contacts

C3 AI Public Relations
Lisa Kennedy
Edelman
415-988-4960

press@c3.ai

Investor Relations

ir@c3.ai

C3.ai

NYSE:AI

Release Versions

Contacts

C3 AI Public Relations
Lisa Kennedy
Edelman
415-988-4960

press@c3.ai

Investor Relations

ir@c3.ai

More News From C3.ai

C3 AI Board Member Jim Hagemann Snabe Appointed European Commission Special Envoy for Industrial AI

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3 AI (NYSE: AI), the enterprise AI application software company, today announced that Jim Hagemann Snabe, a member of its Board of Directors and special advisor to Chairman and Chief Executive Officer Thomas M. Siebel, has been appointed by the European Commission as Special Envoy for Industrial Artificial Intelligence. In this role, he will advise Commission President Ursula von der Leyen and Executive Vice-President Henna Virkkunen. Snabe will take a le...

C3 AI and Shell Expand Collaboration, Scaling Reliability AI Deployment Across Global Asset Operations

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3 AI (NYSE: AI) today announced that Shell Information Technology International B.V. (“Shell”) is extending its long-standing collaboration with C3 AI across its global operations. C3 AI has worked with Shell since 2018 to deploy and operate an enterprise-scale predictive maintenance program, monitoring more than 13,000 pieces of equipment. Under a new multi-year agreement, Shell will extend its deployment of C3 AI Reliability to enhance its operations, e...

C3 AI Announces Fiscal Fourth Quarter and Full Fiscal Year 2026 Results

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3.ai, Inc. (“C3 AI,” “C3,” or the “Company”) (NYSE: AI), the Enterprise AI application software company, today announced financial results for its fiscal fourth quarter and full fiscal year ended April 30, 2026. “We have a well-defined strategy, a restructured organization, new executive leadership, and a detailed execution plan now in place with the singular focus of increasing shareholder value through topline revenue growth, cash generation, and non-GA...
Back to Newsroom